Thibault Moreau Selected Research

lignoceric acid (tetracosanoic acid)

10/2018	Modulation of Kv3.1b potassium channel level and intracellular potassium concentration in 158N murine oligodendrocytes and BV-2 murine microglial cells treated with 7-ketocholesterol, 24S-hydroxycholesterol or tetracosanoic acid (C24:0).
10/2017	Evidence of K+ homeostasis disruption in cellular dysfunction triggered by 7-ketocholesterol, 24S-hydroxycholesterol, and tetracosanoic acid (C24:0) in 158N murine oligodendrocytes.
1/2015	Impact of C24:0 on actin-microtubule interaction in human neuronal SK-N-BE cells: evaluation by FRET confocal spectral imaging microscopy after dual staining with rhodamine-phalloidin and tubulin tracker green.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thibault Moreau Research Topics

Disease

28	Multiple Sclerosis 11/2021 - 05/2008
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 07/2015
8	Relapsing-Remitting Multiple Sclerosis 01/2022 - 02/2009
6	Stroke (Strokes) 06/2012 - 07/2003
5	Progressive Multifocal Leukoencephalopathy 01/2021 - 12/2016
5	Mitochondrial Diseases (Mitochondrial Disease) 11/2019 - 01/2017
5	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2015
3	Dementia (Dementias) 01/2019 - 09/2005
3	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 09/2008
2	COVID-19 01/2021 - 01/2020
2	Transverse Myelitis (Necrotizing Myelitis) 01/2020 - 05/2011
2	Rupture 10/2018 - 01/2017
2	Neuromyelitis Optica (Devic's Disease) 09/2017 - 05/2011
2	Parkinson Disease (Parkinson's Disease) 12/2016 - 08/2011
2	Ischemic Stroke 06/2012 - 07/2003
2	Hypertension (High Blood Pressure) 01/2010 - 02/2004
2	Atrial Fibrillation 01/2010 - 02/2004
1	Neurosarcoidosis 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Disease Progression 01/2021
1	Infections 01/2020
1	Myelitis 01/2020
1	Prodromal Symptoms 01/2018
1	Optic Neuritis (Retrobulbar Neuritis) 01/2018
1	Neuroinflammatory Diseases 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 10/2017
1	Inflammation (Inflammations) 12/2016
1	Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia 01/2013
1	Muscular Diseases (Myopathy) 01/2013

Drug/Important Bio-Agent (IBA)

9	Natalizumab (Tysabri)FDA Link 01/2022 - 02/2016
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2016
7	7-ketocholesterolIBA 10/2018 - 07/2015
6	OxysterolsIBA 01/2021 - 12/2016
6	CholesterolIBA 11/2019 - 12/2016
6	LipidsIBA 10/2018 - 12/2016
5	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 02/2016
5	Biotin (Vitamin H)FDA Link 01/2021 - 11/2016
4	Fatty Acids (Saturated Fatty Acids)IBA 11/2019 - 01/2018
4	AnticoagulantsIBA 12/2009 - 07/2003
3	nitazoxanide (NTZ)FDA Link 01/2022 - 08/2017
3	lignoceric acid (tetracosanoic acid)IBA 10/2018 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 10/2018 - 01/2015
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2011 - 12/2009
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	InterferonsIBA 01/2021 - 01/2009
2	AcidsIBA 11/2019 - 01/2017
2	Cardiolipins (Cardiolipin)IBA 11/2019 - 10/2018
2	Dimethyl FumarateIBA 11/2019 - 01/2019
2	Glatiramer Acetate (Copaxone)FDA Link 04/2019 - 02/2009
2	24-hydroxycholesterolIBA 10/2018 - 10/2017
2	Antihypertensive Agents (Antihypertensives)IBA 03/2011 - 12/2009
2	Interferon-betaIBA 01/2009 - 05/2008
1	IronIBA 01/2022
1	Azathioprine (Imuran)FDA LinkGeneric 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	Oligoclonal BandsIBA 10/2021
1	nomegestrol acetateIBA 01/2021
1	SteroidsIBA 01/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	AntibodiesIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	citraconic acid (mesaconic acid)IBA 11/2019
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 11/2019
1	Caspase 3 (Caspase-3)IBA 11/2019
1	teriflunomideIBA 01/2019
1	Progestins (Progestagens)IBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Ion Channels (Ion Channel)IBA 10/2018
1	OxidesIBA 10/2018
1	EnzymesIBA 10/2018
1	Potassium Channels (Potassium Channel)IBA 10/2018
1	Adenosine Triphosphate (ATP)IBA 10/2018
1	Messenger RNA (mRNA)IBA 10/2018
1	PlasmalogensIBA 10/2018
1	Superoxide Dismutase-1IBA 01/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018
1	Phytosterols (Plant Sterols)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	argan oilIBA 10/2017
1	IonsIBA 10/2017
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2017
1	Immunoglobulin G (IgG)IBA 09/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 08/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	Tocopherols (Tocopherol)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	ProfilIBA 01/2017
1	SynucleinsIBA 12/2016
1	TubulinIBA 01/2015

Therapy/Procedure

11	Therapeutics 01/2022 - 02/2004
2	Critical Care (Surgical Intensive Care) 05/2008 - 09/2005
2	Secondary Prevention 09/2005 - 07/2003
1	Cognitive Training 06/2020
1	Analgesia 01/2019